Tele: 561.316.3330
Breaking Medical Device News

Saturday, October 16, 2021
HomeFDACURE™ OPEL-L (S) system Receives FDA Clearance Reports Meditech Spine

CURE™ OPEL-L (S) system Receives FDA Clearance Reports Meditech Spine

Meditech Spine announced they received FDA 510(k) clearance to market the CURE™ Opel-L (S) system, a new lumbar plate option that expands upon the previously cleared CURE™ LP Plate System and compliments its Talos®-A (HA) Interbody system.

With this approval, Meditech will now offer an Interbody/Plate assembly for the anterior lumbar spine. By adding the Opel™-L (S) plating option to the CURE™ LP product line and pairing it with the Talos® A (HA) interbody system, surgeons now have a nearly limitless opportunity to ideally accommodate individual patient anatomy. The new system has an increased screw angulation and repeatable, more precise A/P alignment with an optional All-in-One drill guide during the placement of the device. By combining the Opel™-L (S) and the Talos®-A (HA) Interbody, surgeons have a lower profile system and streamlined technique improving surgical efficiency while maintaining a robust anterior stabilization.

In addition, Meditech is adding and launching hyper-lordotic sizes to its existing Talos®-A (HA) line of osteoconductive PEEK-OPTIMA® HA Enhanced ALIF implants. With the current CURE™ LP system and the FDA clearance of Opel™-L (S), Meditech offers a comprehensive anterior lumbar system that gives surgeons multiple options when treating complex anterior lumbar spinal procedures. Meditech has targeted the initial launch for this integrated system to take place in the 3rd quarter of 2020. This is the first of three anticipated clearances this year for Meditech Spine.

Meditech continues its relationship with CURE International, the namesake of the CURE ACP, an organization that serves children with physical disabilities in underserved areas of the world. A portion of proceeds from the sale of every plate will help CURE International treat patients in underserved areas who are in need of surgical care.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

Global Healthcare Exchange Announces Acquisition of Explorer Surgical

Explorer Surgical will operate as a wholly-owned subsidiary of GHX.

Arlington Scientific Broadens Product Portfolio and Further Expands its Product Offering Through the acquisition of Non-Mammalian Blocking Buffers

Arlington Scientific, Inc. (ASI) is pleased to announce that it has acquired the non-mammalian blocking buffer product line from Clark McDermith, former owner of...

Laborie Medical Technologies Acquires Pelvalon

Laborie was represented by Piper Sandler (financial advisor) and Simpson Thacher & Bartlett LLP (legal advisor). Pelvalon was represented by J.P. Morgan Securities LLC (financial advisor) and Dorsey & Whitney LLP (legal advisor).

Herculite Products, Inc. Promotes Two Employees to New Roles

Paul Flaherty Chief Strategy Officer and Marco Angelone is being promoted to the role of Chief Financial Officer.

Prof. Joseph Kvedar Added to the Sweetch Advisory Board Member

Prof. Josdeph Kvedar is the current chair of the board at the American Telemedicine Association (ATA), formerly VP of Connected Health at Mass-Gen Brigham, co-chair of the American Medical Association (AMA) Digital Medicine Payment Advisory Group, and author of The Internet of Healthy Things and The New Mobile Age.

Sid Bala Named President of HealthChampion

Sid Bala is the former president and chief executive officer of alligatortek, a custom software applications company that was acquired by HealthChampion in 2020 where he led them for 27 years after he founded the business

Cochlear Announces FDA Approval and Clearance of first-of-its-kind Remote Care Capabilities for Nucleus and Baha Systems

The FDA approval for the cochlear implant solution and FDA clearance for the Baha solution is the first step in commercializing the product offering, anticipated spring 2022, and complement Cochlear's existing Remote Care offerings.

By using this website you agree to accept Medical Device News Magazine Privacy Policy